HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Heart Transplantation
Heart Transplantation
It is the serious player It is a surgical procedure in which a flawed or dented heart is supplanted by a healthy and nutritious donor heart that has recently died. If a patient has a heart problem and is unable to recover from treatment, heart transplant procedures are performed.
Risk:
- Denial of the patient's heart.
- Primary graft inability
- Issue if the arteries are not removed.
- Medication side impacts
- Cancer.
Infection control by injecting medicines straight into the bone marrow, creating a pro point of entry into the institutional venous system. Once intravenous entrance is not available, this technique is used to enable fluids and medication. It is also a crucial component of the hospital's intensive care unit when there is an emergency.
Committee Members
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation